InvestorsHub Logo
Followers 29
Posts 9421
Boards Moderated 0
Alias Born 04/30/2006

Re: longterm42 post# 15475

Wednesday, 07/30/2008 9:11:42 AM

Wednesday, July 30, 2008 9:11:42 AM

Post# of 30387
LT, I did not post all those patents using RECAF to be negative. It is just a fact that Dr. Moro is way behind in therapy using RECAF. Others have patents approved and one has a product in trials. The patent filing he announced yesterday may suffer the same fate as his other attempts to attain additional therapy patents. It will be years before he would get results of his filings and even if he perfects a therapy, he has no funds to pursue it and no company will license it without a valid patent. This company will make or break on diagnostics alone. Didn't you notice yesterday that he has totally dropped therapy research to concentrate on ELISA diagnostics? There is a big reasons for that. One has a definite potential for money, the other does not.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.